Cite
HARVARD Citation
Tardieu, M. et al. (2021). Cutaneous adverse events in children treated with vemurafenib for refractory BRAFV600E mutated Langerhans cell histiocytosis. Pediatric blood & cancer. 68 (9), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tardieu, M. et al. (2021). Cutaneous adverse events in children treated with vemurafenib for refractory BRAFV600E mutated Langerhans cell histiocytosis. Pediatric blood & cancer. 68 (9), p. n/a. [Online].